ReviewJournal of pancreatology2026
Photon-counting CT for pancreatic cancer: advancing precision imaging and virtual surgical navigation.
Review in Journal of pancreatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic Imaging of Pancreatic and Biliary Involvement in IgG4-Related Disease: Key Imaging Features, Diagnostic Criteria and Differential Diagnosis.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic cancer remains highly lethal, with a 5-year survival below 15%. While surgical resection is the only potentially curative approach, conventional imaging often fails to clearly delineate tumor boundaries and adjacent anatomy, compromising preoperative planning and surgical precision. This review summarizes recent advancements in photon-counting computed tomography (PCCT) for pancreatic cancer imaging and surgical planning. A literature search was conducted to identify relevant studies published between 2018 and 2025, focusing on PCCT's role in tumor visualization, comprehensive vascular mapping including invasion and anatomical variants, lymph node detection, and surgical navigation. PCCT provides ultra-high spatial resolution and intrinsic spectral imaging capabilities, significantly improving the visualization of low-contrast pancreatic tumors and subtle anatomical details. Emerging preliminary clinical evidence highlights PCCT's potential to enhance diagnostic accuracy, precisely assess tumor resectability, and guide surgical interventions. As clinical adoption expands, PCCT may become a key imaging tool for precision management of pancreatic cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.